Anti-V5-tag pAb-Agarose (Polyclonal Antibody)
V5-tag Polyclonal Antibody.
Polyclonal Antibody conjugated to agarose of gel: 200 µl targeting V5-tag for IP.
|Size:||Gel: 200 µL|
|Research Area / Disease:||Epitope Tag|
|Formulation:||400 μg of anti-V5-tag polyclonal antibody covalently coupled to 200 μl of agarose gel and provided as a 50% gel slurry suspended in PBS containing preservative (0.09% sodium azide) for a total volume of 400 μl.*Azide|
|Isotype:||Affinity Purified Ig|
|Immunogen:||Binding synthetic peptide carrier protein (CP-GKPIPNPLLGLDST)|
|Source:||This antibody was purified from rabbit serumusing affinity column. The rabbit was immunized withcarrier protein (CP) conjugated synthetic peptide,CP-GKPIPNPLLGLDST.|
|Reactivity:||This antibody recognizes V5-tagpeptide sequence (GKPIPNPLLGLDST) onImmunoprecipitation.|
|Regulatory Statement:||For Research Use Only. Not for use in diagnostic procedures.|
- Uenaka T et al. In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson’s disease. Hum Mol Genet. 27, 3974-3985 (2018)
- Taira J et al. Dephosphorylation of clustered phosphoserine residues in human Grb14 by protein phosphatase 1 and its effect on insulin receptor complex formation. J Pept Sci. 25, e3207 (2019)